COVANCE Stock Quote

$107.12 arrow  Change: -0.04 %Chge: -0.04% Vol: 179,996
End Of Day Prices
High: 107.35 | Low: 107.01 | Open: 107.17 | Close: 107.12
52 Wk High: 107.35 | 52 Wk Low: 107.01 | Todays Pivot: 107.16
Sector: Healthcare and Pharmaceuticals add stock to watch list

CVD Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Brookdale Sr Living 23.27 red arrow 45,369
Hologic 21 red arrow 174,372
Celgene 106.85 green arrow 249,127
Health Net 29.39 red arrow 684,900
Humana 60.08 green arrow 1,309,700
Community Health Sys Newco 61.6 red arrow 68,839
Mednax 57.54  arrow 40,711
Alexion Pharmaceuticals 65.58 green arrow 101,330

Above is a small selection of related companies to Covance which compete alongside CVD within the Healthcare and Pharmaceuticals sector. To see more related companies to CVD, view our stock market today information page.

Online News For Covance

Treatment goals, benefits in CKD, CVD may need revisiting

PHILADELPHIA — Lack of data may lead to changes in treatment goals and benefits for patients with cardiovascular disease and chronic kidney disease in addition to diabetes, according to a speaker here ...


3D map of CVD genetic interactions could aid future treatments

A 3D map of genetic interactions in CVD could aid researchers investigating future treatments for heat attacks, heart failure and heart rhythm disorders. A 3D map of key gene interactions in cardiovas...


Global CVD Diamond Market is expected to reach 200 million USD by 2025 – QY Research

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods ...


Institutional Investors Sentiment Indicator of CVD Equipment Corp (NASDAQ:CVV) Falls in 2018 Q1

CVD Equipment Corp (NASDAQ:CVV) institutional sentiment decreased to 0.78 in 2018 Q1. Its down -1.22, from 2 in 2017Q4. The ratio has dropped, as 7 funds started new or increased stock positions, whil...


Cardiologists should consider prescribing GLP1 agents for CVD prevention in type 2 diabetes

PHILADELPHIA — Although endocrinologists may routinely prescribe the newer classes of diabetes drugs approved for cardiovascular risk reduction, cardiologists and primary care providers should also co...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Covance quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for CVD to choose from. Visit here to build your stock quote widget »